High-dimensional cellular and spatial analysis for AML research
Official title: Core C: High Dimensional Cellular and Spatial Analysis
Funded at Fred Hutchinson Cancer Center · NIH-11420383 · Data updated 2026-11-12
A core team at a major cancer center is helping multiple AML projects analyze very complex single-cell and spatial data to uncover new biology and hypotheses.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | August 28, 1997 |
| Project end | July 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $658,874 |
| NIH project number | 5P01CA018029-50 |
| Project ID | NIH-11420383 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable to patient participation in this core; future patient impact arises from AML research informed by the core’s analyses.
✕Less likely to help
Patients would not be directly enrolled in this core’s activities.
What this research studies
This core provides expert support for single-cell sequencing and spatial analysis, helping researchers manage and interpret large, complex datasets. It collaborates with biostatistics and data management to test ideas and discover new findings. The goal is to enable precise immune profiling, tissue mapping, and data-driven discovery that could inform future AML treatments.
Why it matters
Potential benefit: People with AML may benefit from faster discovery of cell- and tissue-level targets that could guide new therapies.
How similar studies have gone: Similar high-dimensional analyses have yielded new cell types and hypotheses in cancer research, supporting the approach's potential.
Where this research is happening
-
Fred Hutchinson Cancer Center
Seattle, United States Active
Researchers
- Principal investigator: Newell, Evan — Fred Hutchinson Cancer Center
- Study coordinator: Newell, Evan
Related research
Other NIH-funded projects on the same topics.
-
How brain glia prune neuron fragments in a worm model
Researchers study how brain support cells called glia remove pieces of living neurons in a tiny worm to learn about brain aging and diseases like Alzheimer's.
-
Understanding and Targeting Lineage Plasticity in Prostate Cancer with Genomic-Based Neoadjuvant Therapy
A broad research program at Fred Hutchinson Cancer Center is exploring how aggressive prostate cancers change their cell states in response to therapy and how to block these changes.
-
Personalized cancer drug testing on patient tumor cells
Aiming to test many FDA-approved cancer drugs on a patient’s own tumor cells to identify effective options when standard therapies fail.
-
MOSAAIC: Using health records to track heart disease in Asian American Communities
A big, dedicated effort is testing whether electronic health records can more quickly and accurately track heart and blood vessel problems in Asian American populations.
-
Targeting gut microbes to prevent progression to multiple myeloma
Researchers are testing how specific gut bacteria might trigger immune changes linked to early blood cancer stages and whether targeting these microbes could help prevent progression to multiple myeloma.
-
eDyNAmiC: Understanding extrachromosomal DNA in cancer and how it drives aggressiveness
A cancer research project at Fred Hutchinson Cancer Center is studying abnormal circular DNA pieces (ecDNA) that help cancers grow and resist treatment, with the aim of finding ways to help patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.